Siemens Healthineers AG (SHL.DE)
- Previous Close
52.94 - Open
53.38 - Bid 53.32 x --
- Ask 53.36 x --
- Day's Range
53.24 - 54.08 - 52 Week Range
44.39 - 58.14 - Volume
226,348 - Avg. Volume
658,627 - Market Cap (intraday)
59.516B - Beta (5Y Monthly) 0.73
- PE Ratio (TTM)
39.51 - EPS (TTM)
1.35 - Earnings Date May 7, 2024
- Forward Dividend & Yield 0.95 (1.79%)
- Ex-Dividend Date Apr 19, 2024
- 1y Target Est
59.50
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
www.siemens-healthineers.comRecent News: SHL.DE
Performance Overview: SHL.DE
Trailing total returns as of 4/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHL.DE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHL.DE
Valuation Measures
Market Cap
59.07B
Enterprise Value
57.76B
Trailing P/E
39.21
Forward P/E
19.12
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.73
Price/Book (mrq)
3.31
Enterprise Value/Revenue
2.65
Enterprise Value/EBITDA
15.01
Financial Highlights
Profitability and Income Statement
Profit Margin
6.97%
Return on Assets (ttm)
3.00%
Return on Equity (ttm)
8.40%
Revenue (ttm)
21.78B
Net Income Avi to Common (ttm)
1.52B
Diluted EPS (ttm)
1.35
Balance Sheet and Cash Flow
Total Cash (mrq)
1.47B
Total Debt/Equity (mrq)
89.44%
Levered Free Cash Flow (ttm)
1.64B
Research Analysis: SHL.DE
Company Insights: SHL.DE
SHL.DE does not have Company Insights